[1] HU SB, XU L, FENG ZF, et al.Effects of Tanreqing on TLRs/NF-κB Signaling Pathway-Related Cytokines and Airway Remodeling of Peripheral Blood Mononuclear Cells in Patients with AECOP[J]. Chinese and Foreign Medical Research(中外医学研究), 2023, 21(12): 10-14. [2] LIAN LS.Clinical Research on Efficacy of Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECPD) with Tanreqing Injection and Its Effects on Tumor Necrosis Factorα(TNF-α), Interleukin-8 (IL-8) in the Peripheral Blood[D]. Guangzhou: Guangzhou University of Chinese Medicine, 2007. [3] CHEN CB.Clinical Study on Tanreqing Injection Combined with Salmeterol Xinafoate and Fluticasone Propionate in Treatment of Acute Exacerbation of Chronic Obstructive Disease[J]. Drugs & Clinic(现代药物与临床), 2018, 33(10): 2571-2575. [4] LUO Q, PENG B, WEI XL, et al.Proteomic Study of Tanreqing Injection on Chronic Obstructive Pulmonary Disease Model Rats[J]. Chinese Traditional and Herbal Drugs(中草药), 2023, 54(21): 7078-7085. [5] HOU H, LI Y, XU Z, et al.Applications and Research Progress of Traditional Chinese Medicine Delivered via Nasal Administration[J]. Biomedicine & Pharmacotherapy, 2023, 157: 113933. [6] ZHAO LN.Analysis of the Effect of Salbutamol Combined with Ipratropium Bromide Aerosol Inhalation in the Treatment of Chronic Obstructive Pulmonary Disease[J]. Chinese Journal of Modern Drug Application(中国现代药物应用), 2023, 17(2): 16-20. [7] CHEN TF, SONG L, GAO YH, et al.Pharmacokinetics of Baicalin and Oroxyloside in Plasma and Different Tissues of Rats after Transnasal Aerosol Inhalation and Intravenous Injection of Tanreqing[J]. Frontiers in Pharmacology, 2022, 13: 951613. [8] WANG C, XU J, YANG L, et al.Prevalence and Risk Factors of Chronic Obstructive Pulmonary Disease in China (the China Pulmonary Health [CPH] Study): a National Cross-Sectional Study[J]. Lancet, 2018, 391(10131): 1706-1717. [9] Diagnostic Key Points of the Chronic Obstructive Pulmonary Disease (COPD) Diagnosis and Treatment Guidelines (2021 Revision)[J]. Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease(实用心脑肺血管病杂志), 2021, 29(6): 134. [10] Recommendations from the Expert Consensus on Immunomodulatory Therapy for Chronic Obstructive Pulmonary Disease (COPD)[J]. Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease(实用心脑肺血管病杂志), 2022, 30(8): 7. [11] CHEN YH, FENG CL, WANG J, et al.Expert Consensus on Immun-omodulatory Therapies for Chronic Obstructive Pulmonary Disease[J]. Chinese General Practice(中国全科医学), 2022, 25(24): 2947-2959. [12] WANG GH, LI XL, LIU XP, et al.Aerosol Inhalation of Tanreqing Injection in the Treatment of Chronic Obstructive Pulmonary Disease: a Meta-Analysis[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2023, 20(5): 544-552. [13] NONG DM, JIANG FZ, WU XL, et al.The Clinical Effects of Bronchiolitis Treated by Tanreqing Injection in Different Ways[J]. China Modern Doctor(中国现代医生), 2009, 47(10): 34-35. [14] LIU LT, HOU HP, ZHANG GP, et al.Effect of Puerarin on the Oxidative Damage of A549Cells Induced by Cigarette Smoke Extract[J]. Pharmacology and Clinics of Chinese Materia Medica(中药药理与临床), 2019, 35(6): 37-41. [15] KUME H, YAMADA R, SATO Y, et al.Airway Smooth Muscle Regulated by Oxidative Stress in COPD[J]. Antioxidants (Basel), 2023, 12(1): 142. [16] KIRKHAM PA, BARNES PJ.Oxidative Stress in COPD[J]. Chest, 2013, 144(1): 266-273. [17] CHEN Q, NWOZOR KO, VAN DEN BERGE M, et al. From Differential DNA Methylation in COPD to Mitochondria: Regulation of AHRR Expression Affects Airway Epithelial Response to Cigarette Smoke[J]. Cells, 2022, 11(21): 3423. [18] FAHERTY L, KENNY S, CLOONAN SM.Iron and Mitochondria in the Susceptibility, Pathogenesis and Progression of COPD[J]. Clinical Science (London, England : 1979), 2023, 137(3): 219-237. |